Pharming Group N.V. Sponsored ADR (PHAR) vs Prime Medicine, Inc. (PRME)
- Pharming Group N.V. Sponsored ADR PHAR 9.36 −2.80%
- Prime Medicine, Inc. PRME 3.47 −3.88%
Pharming Group N.V. Sponsored ADR and Prime Medicine, Inc. are both Biotechnology companies. Pharming Group N.V. Sponsored ADR and Prime Medicine, Inc. are of similar size ($681.6M and $654.8M). Prime Medicine, Inc. has negative trailing earnings, so its P/E is not meaningful; Pharming Group N.V. Sponsored ADR trades at 62.4×. Pharming Group N.V. Sponsored ADR grew revenue faster over the last twelve months: 7.85% against −17.9%. Pharming Group N.V. Sponsored ADR has the higher net margin (2.55% vs −4,613.1%) and the higher return on invested capital (5.50% vs 0.00%). Across the 18 metrics below, Pharming Group N.V. Sponsored ADR leads on 14 and Prime Medicine, Inc. on 4.
Valuation
Profitability
| Metric | PHAR | PRME | Biotechnology median |
|---|---|---|---|
| Gross margin | 86.54% | 100.00% | 65.16% |
| Operating margin | 5.04% | (4,824.94%) | 0.00% |
| Net margin | 2.55% | (4,613.11%) | 0.00% |
| Free cash flow margin | 9.38% | (3,850.92%) | 0.00% |
| Return on equity | 3.67% | (373.29%) | (56.36%) |
| Return on assets | 2.05% | (71.16%) | (48.04%) |
| Return on invested capital | 5.50% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack